Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study

Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study - Clinical trial of advanced stage childhood lymphoblastic lymphoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002212

Enrollment

124

Registered

2009-07-26

Start date

2005-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced stage lymphoblastic lymphoma of children.

Interventions

Treatment regimen has fundamentally BFM backbone and intensified with pulse type early and late maintenance phase, which consisted with MTX, VCR, L-ASP, PSL, 6MP, and CPA.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with advanced stage T and B cell lymphoblastic lymphoma

Exclusion criteria

Exclusion criteria: 1, Down's syndrome 2, previous malignancy of any type 3, Prior stem cell or organ transplantation 4, Congenital or acquired immunodeficiency

Design outcomes

Primary

Measure	Time frame
3 year event-free survival	—

Secondary

Measure	Time frame
(1) 3year overall survival (2)Incidence of therapy-rerated severe toxicity	—

Countries

Japan

Contacts

Public Contactshosuke Sunami

Japanese Red Cross Narita Hospital Department of Pediatrics

s-sunami@sc4.so-net.ne.jp0476222311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026